OCT 15, 2026 · JOURNAL ARTICLE
GLP-1 and GIP Receptor Agonists and the Gut Microbiota: Mechanisms, Microbial Changes and Therapeutic Implications
African Journal of Biomedical Research
Glucagon-like peptide-1 (GLP-1) receptor agonists are established therapies for type 2 diabetes mellitus and obesity, while dual GLP-1/glucose-dependent insulinotropic polypeptide